Skip to main navigation

+44 (0)20 8154 4600
info@achillestx.com

Home
About Us
Science
Publications
Pipeline
- PIPELINE
- EXPANDED ACCESS
Investors & Media
CAREERS
Contact

Press Releases

Home
About Us
Science
Publications
Pipeline
- PIPELINE
- EXPANDED ACCESS
Investors & Media
CAREERS
Contact

Year

All News
2024
2023
2022
2021
2020
2019
2018
2017
2016

Nov 19 2020

Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours

Read More +

Nov 17 2020

Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer

Read More +

Oct 7 2020

Achilles Therapeutics appoints Professor Karl Peggs as Chief Medical Officer

Read More +

Oct 7 2020

Achilles Therapeutics appoints Daniel Hood as Chief Legal Officer

Read More +

Jun 23 2020

Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer

Read More +

May 29 2020

Achilles Therapeutics doses first patient in Phase I/II Study in recurrent or metastatic malignant melanoma with first TIL therapy to specifically target clonal neoantigens

Read More +

May 28 2020

Achilles Therapeutics to present at Jefferies Virtual Healthcare Conference

Read More +

May 13 2020

Achilles Therapeutics announces formation of Scientific Advisory Board

Read More +

Apr 22 2020

Achilles Therapeutics to present a manufacturing update at the virtual 2020 AACR Annual Meeting

Read More +

Apr 7 2020

Achilles Therapeutics appoints Carsten Boess to the Board of Directors

Read More +

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Current page 8
Page 9
Page 10
Next page
Last page

Print Page

RSS Feeds

Email Alerts

Contact IR

Home
About Us
Science
Publications
Pipeline
Investors & Media
Work with us
Contact

UK Headquarters:
Achilles Therapeutics plc
245 Hammersmith Road
London
W6 8PW, UK

US Headquarters:
Achilles Therapeutics US, Inc.
401 N. Broad Street
Suite M121
Philadelphia, PA 19108

+44 (0)20 8154 4600
info@achillestx.com

© Copyright - Achilles Therapeutics plc.

Achilles Therapeutics plc (13027460) is registered in England and Wales. The registered office is at 245 Hammersmith Road, London, W6 8PW.

Privacy & Cookie Policy

Terms & Conditions